We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.89B
AUM Growth
-$1.49B
Cap. Flow
-$1.55B
Cap. Flow %
-17.42%
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124

Top Buys

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$37.3M
2
MMP
Magellan Midstream Partners, L.P.
MMP
+$31.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
NEM icon
Newmont
NEM
+$27.4M
5
CMI icon
Cummins
CMI
+$24.3M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$430M
2
JPM icon
JPMorgan Chase
JPM
+$168M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$132M
4
YUM icon
Yum! Brands
YUM
+$105M
5
PFE icon
Pfizer
PFE
+$92.8M

Sector Composition

Rank Sector Weight
1 Energy 59.33%
2 Technology 6.01%
3 Healthcare 4.63%
4 Consumer Discretionary 3.72%
5 Financials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
951
Pacific Biosciences
PACB
$422M
– –
-16,557
Closed -$423K
PARA
952
DELISTED
Paramount Global Class B
PARA
– –
-9,347
Closed -$369K
PBYI icon
953
Puma Biotechnology
PBYI
$406M
– –
-49,974
Closed -$350K
PGR icon
954
Progressive
PGR
$124B
– –
-18,873
Closed -$1.71M
PLD icon
955
Prologis
PLD
$138B
– –
-13,059
Closed -$1.64M
PLYM
956
DELISTED
Plymouth Industrial REIT
PLYM
– –
-31,245
Closed -$711K
PRGO icon
957
Perrigo
PRGO
$1.4B
– –
-5,175
Closed -$245K
QDEL icon
958
QuidelOrtho
QDEL
$1.09B
– –
-1,448
Closed -$204K
QNCX icon
959
Quince Therapeutics
QNCX
$17.5M
– –
-182
Closed -$3.33M
RDNT icon
960
RadNet
RDNT
$4.84B
– –
-12,513
Closed -$367K
RDY icon
961
Dr. Reddy's Laboratories
RDY
$9.82B
– –
-39,860
Closed -$519K
RNAC icon
962
Cartesian Therapeutics
RNAC
$232M
– –
-4,702
Closed -$587K
ROL icon
963
Rollins
ROL
$18.6B
– –
-57,623
Closed -$2.04M
SAH icon
964
Sonic Automotive
SAH
$3.15B
– –
-6,419
Closed -$337K
SBUX icon
965
Starbucks
SBUX
$118B
– –
-14,460
Closed -$1.59M
SCS
966
DELISTED
Steelcase
SCS
– –
-13,982
Closed -$177K
SGMO
967
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-178,133
Closed -$1.6M
SJM icon
968
J.M. Smucker
SJM
$12.6B
– –
-130,000
Closed -$15.6M
FTH
969
Faeth Therapeutics
FTH
$729M
– –
-1,874
Closed -$394K
STAA icon
970
STAAR Surgical
STAA
$1.16B
– –
-3,063
Closed -$394K
STX icon
971
Seagate
STX
$193B
– –
-275,264
Closed -$22.7M
SVC
972
Service Properties Trust
SVC
$1.1B
– –
-13,538
Closed -$759K
SVRA icon
973
Savara
SVRA
$1.13B
– –
-143,400
Closed -$198K
TGTX icon
974
TG Therapeutics
TGTX
$8.58B
– –
-175,064
Closed -$5.83M
TRUP icon
975
Trupanion
TRUP
$1.05B
– –
-3,115
Closed -$242K
37 38
39
40 41

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ALPS Advisors held 1,012 positions worth $8.89B, down 14% from $10.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $1.55B in Q4 2021, closing 124 positions and reducing 302 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $430M position sold in full.

By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.

Against the trend, ALPS Advisors opened a new position in Bristol-Myers Squibb worth $29.6M.

  • ALPS Advisors's largest Q4 2021 buy was Bristol-Myers Squibb: 474,459 shares worth $29.6M.
  • ALPS Advisors added most to Energy Transfer Partners in Q4 2021, an estimated $37.3M increase.
  • ALPS Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $168M.
  • ALPS Advisors fully exited Berkshire Hathaway Class A in Q4 2021, selling an estimated $430M.
  • ALPS Advisors's ten largest holdings make up 48% of its $8.89B portfolio in Q4 2021.
  • ALPS Advisors opened 106 new positions and closed 124 in Q4 2021.
  • ALPS Advisors's portfolio value fell 14% quarter-over-quarter to $8.89B.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.